Press releases

(Thomson Reuters ONE via COMTEX) --New Data Presented at TCT and Published by JAMA Affirms Excellent Safety Profile of Zotarolimus-Eluting Stents SAN FRANCISCO -- Oct. 31, 2013 -- According to...

(Thomson Reuters ONE via COMTEX) --Presented at TCT and Published by The Lancet, Results of DUTCH PEERS Negate Notion of Class Effect with Structural Stability of 'More Flexible and Highly...

Thomson Reuters ONE via COMTEX) --Longest-term data from the first randomized, controlled trial of renal denervation presented at the 25th Annual Transcatheter Cardiovascular Therapeutics (TCT)...

Thomson Reuters ONE via COMTEX) --First Rigorous Prospective Analysis of Extreme Risk Patients Presented at TCT13 SAN FRANCISCO and MINNEAPOLIS - Oct. 30, 2013 - Following the first U.S. data...

SAN FRANCISCO and MINNEAPOLIS - Oct. 29, 2013 - Medtronic, Inc. (NYSE: MDT) today announced the highly anticipated results from the CoreValve U.S. Pivotal Trial, the first U.S. data presented on...

Medtronic, Inc. (NYSE: MDT) today provided the following statement: As part of a patent opposition proceeding, the European Patent Office (EPO) today issued a preliminary opinion on the validity...

(Thomson Reuters ONE via COMTEX) --Long-Time Market Leader Introduces U.S. Cardiologists to Greater Power and Superior Deliverability of Next-Generation 'Export Advance' Aspiration Catheter...

Thomson Reuters ONE via COMTEX) --MEMPHIS, Tenn. - Oct. 21, 2013 - Medtronic, Inc. (NYSE: MDT) the world leader in spinal technology, announced today the launch of the first procedure that allows...

Thomson Reuters ONE via COMTEX) --First Patients Successfully Treated With Novel 'CoreValve Evolut R' Transcatheter Valve MINNEAPOLIS - Oct. 22, 2013 - Medtronic, Inc. (NYSE: MDT) today announced...

Medtronic takes device security and any threat to patient safety seriously. Medtronic is actively engaged with security research firms and regularly conducts and uses independent assessments to...